These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 1349341

  • 21. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
    Elsworth JD, Brittan MS, Taylor JR, Sladek JR, Redmond DE, Innis RB, Zea-Ponce Y, Roth RH.
    Brain Res; 1998 Jun 08; 795(1-2):55-62. PubMed ID: 9622593
    [Abstract] [Full Text] [Related]

  • 22. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
    Graham WC, Sambrook MA, Crossman AR.
    Brain Res; 1993 Feb 05; 602(2):290-303. PubMed ID: 8095431
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS.
    Front Biosci; 2003 Sep 01; 8():a155-66. PubMed ID: 12957824
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys.
    Villalba RM, Lee H, Smith Y.
    Exp Neurol; 2009 Feb 01; 215(2):220-7. PubMed ID: 18977221
    [Abstract] [Full Text] [Related]

  • 28. Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys.
    Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.
    Brain Res; 1996 May 06; 719(1-2):129-37. PubMed ID: 8782872
    [Abstract] [Full Text] [Related]

  • 29. Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment.
    Alexander GM, Schwartzman RJ, Grothusen JR, Brainard L, Gordon SW.
    Brain Res; 1993 Oct 22; 625(2):276-82. PubMed ID: 8275309
    [Abstract] [Full Text] [Related]

  • 30. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
    Pierot L, Desnos C, Blin J, Raisman R, Scherman D, Javoy-Agid F, Ruberg M, Agid Y.
    J Neurol Sci; 1988 Sep 22; 86(2-3):291-306. PubMed ID: 2975699
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Yoshimura N, Mizuta E, Yoshida O, Kuno S.
    J Pharmacol Exp Ther; 1998 Jul 22; 286(1):228-33. PubMed ID: 9655864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.